Rimegepant for the Acute Treatment of Migraine: Subgroup Analyses From 3 Phase 3 Clinical Trials by Triptan Treatment Experience

被引：0
|
作者：
Jensen, C. M. [1 ]
Lipton, R. [2 ]
Blumenfeld, A. [3 ]
Croop, R. [1 ]
Thiry, A. C. [1 ]
L'Italien, G. [1 ]
Morris, B. [1 ]
Coric, V. [1 ]
Goadsby, P. [4 ,5 ,6 ]
机构：
[1] Biohaven Pharmaceut, New Haven, CT USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
[3] Headache Ctr Southern Calif, Carlsbad, CA USA
[4] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England
[5] Kings Coll London, SLaM Biomed Res Ctr, London, England
[6] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2022年 / 23卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P115
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Rimegepant for the Acute Treatment of Migraine: Subgroup Analyses From 3 Phase 3 Clinical Trials by Triptan Treatment Experience
    Jensen, Christopher M.
    Lipton, Richard B.
    Blumenfeld, Andrew
    Croop, Robert
    Thiry, Alexandra
    L'Italien, Gilbert
    Morris, Beth A.
    Coric, Vladimir
    Goadsby, Peter J.
    [J]. CEPHALALGIA, 2022, 42 (1_SUPPL) : 116 - 117
  • [2] Rimegepant for the Acute Treatment of Migraine in Patients with a History of Triptan Treatment Failure: Pooled Results From 3 Phase 3 Clinical Trials
    Jensen, Christopher
    Lipton, Richard
    Blumenfeld, Andrew
    Croop, Robert
    Thiry, Alexandra
    L'Italien, Gilbert
    Morris, Beth
    Coric, Vlad
    Goadsby, Peter
    [J]. NEUROLOGY, 2021, 96 (15)
  • [3] Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials
    Lipton, Richard B.
    Blumenfeld, Andrew
    Jensen, Christopher M.
    Croop, Robert
    Thiry, Alexandra
    L'Italien, Gilbert
    Morris, Beth A.
    Coric, Vladimir
    Goadsby, Peter J.
    [J]. CEPHALALGIA, 2023, 43 (02)
  • [4] Rimegepant for the acute treatment of migraine: Subgroup analyses from 3 phase 3 clinical trials by number of triptans previously tried and failed
    Lipton, R. B.
    Blumenfeld, A. M.
    Jensen, C. M.
    Croop, R.
    Thiry, A. C.
    L'Italien, G. J.
    Morris, B. A.
    Coric, V
    Goadsby, P. J.
    [J]. HEADACHE, 2021, 61 : 144 - 145
  • [5] Rimegepant for the Acute Treatment of Migraine: Subgroup Analyses From 3 Phase 3 Clinical Trials by Number of Triptans Previously Tried and Failed
    Jensen, C. M.
    Lipton, R. B.
    Blumenfeld, A. M.
    Croop, R.
    Thiry, A.
    L'Italien, G.
    Morris, B.
    Coric, V.
    Goadsby, P. J.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 99 - 100
  • [6] Rimegepant for the Acute Treatment of Migraine: Subgroup Analyses From 3 Phase 3 Clinical Trials by Number of Triptans Previously Tried and Failed
    Jensen, C. M.
    Lipton, R. B.
    Blumenfeld, A. M.
    Croop, R.
    Thiry, A.
    L'Italien, G.
    Morris, B.
    Coric, V.
    Goadsby, P. J.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 148 - 148
  • [7] Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials
    Dodick, David W.
    Pavlovic, Jelena M.
    Newman, Lawrence C.
    Lipton, Richard B.
    Thiry, Alexandra
    Morris, Beth A.
    Coric, Vladimir
    Croop, Robert
    [J]. CEPHALALGIA, 2019, 39 : 188 - 189
  • [8] Rimegepant 75 mg is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Results From 3 Phase 3 Trials
    Levin, Morris
    Buse, Dawn
    Blumenfeld, Andrew
    Lipton, Richard
    Stock, Elyse
    Thiry, Alexandra
    Conway, Charlie
    Jensen, Christopher
    Morris, Beth
    Coric, Vladimir
    Croop, Robert
    [J]. NEUROLOGY, 2020, 94 (15)
  • [9] Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials
    Pavlovic, Jelena
    Dodick, David
    Newman, Lawrence
    Lipton, Richard
    Stock, Elyse
    Thiry, Alexandra
    Conway, Charles
    Jensen, Christopher
    Morris, Beth
    Coric, Vladimir
    Croop, Robert
    [J]. NEUROLOGY, 2020, 94 (15)
  • [10] Rimegepant 75 mg is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Results From 3 Phase 3 Trials
    Buse, Dawn
    Blumenfeld, Andrew
    Lipton, Richard B.
    Thiry, Alexandra
    Morris, Beth A.
    Coric, Vladimir
    Croop, Robert
    [J]. CEPHALALGIA, 2019, 39 : 187 - 188
12345